The 'real world' utility of miRNA patents: lessons learned from expressed sequence tags.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 21301436.
- Also identified by DOI 10.1038/nbt.1765.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Strategies are needed for drafting miRNA patent applications, in light of the existing patent landscape and genomic patent strategies of the past decades.
Medical subject headings
- Biotechnology
- Drug Industry
- Intellectual Property
- MicroRNAs
- Patents as Topic